Related Experiment Videos

Congenital tuberculosis presenting as acute cervical lymphadenitis in a 28-week preterm infant

Mengmeng Ge1, Lan Zhang1, Liyuan Hu2

  • 1Division of Neonatology, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China.

Insights

Congenital tuberculosis is rare in preterm infants, often presenting as localized infections. Early suspicion and maternal evaluation are crucial for timely diagnosis and treatment.

Area of Science:

  • Neonatal Medicine
  • Infectious Diseases
  • Pediatric Tuberculosis

Background:

  • Congenital tuberculosis (TB) is exceptionally rare in extremely low birthweight infants.
  • Neonatal intensive care unit (NICU) settings present unique diagnostic challenges.

Purpose of the Study:

  • To report a case of atypical congenital tuberculosis in a preterm infant.
  • To highlight diagnostic delays and suggest clinical considerations for NICU physicians.

Main Methods:

  • Case report of an infant born at 28 weeks' gestation.
  • Identification of Mycobacterium tuberculosis via culture and molecular testing of surgical drainage fluid.
  • Review of 20 case reports on congenital TB.

Main Results:

  • The infant presented with isolated cervical lymphadenitis at 84 days of life.
  • Diagnosis was delayed due to low clinical suspicion, concurrent cytomegalovirus (CMV) infection, and empirical linezolid therapy.
  • A pattern emerged linking maternal urogenital/endometrial TB to localized neonatal head and neck infections.

Conclusions:

  • Congenital TB in preterm infants can manifest atypically as late-onset, localized suppuration.
  • Clinicians should consider TB in antibiotic-refractory localized infections within the NICU.
  • Occult maternal pelvic TB should be evaluated in cases of atypical neonatal infections, especially post-in-vitro fertilization (IVF).

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...